Sepsis – Treatment

Report Overview

In 2014, US healthcare spending exceeded $3.0 trillion with nearly 1/3 spent on hospitalizations. Informed by real-world data from an Electronic Health Record (EHR) database of clinical and administrative records spanning 273 million encounters for 60 million patients in 600+ hospitals across the US, Boston Strategic Partners (BSP) Real World data report, Hospital-Treated Sepsis: Treatment, estimates 30% of all hospital discharges involve treatment of infectious organisms. Sepsis is responsible for an estimated 12% of all hospital stays. At an average cost of $15,500 per occurrence, we estimate that hospitalizations for severe infections account for $212 billion in annual spending or 7% of total healthcare expenditure. In this report, we conduct an in-depth analysis of sepsis patient characteristics, medication management, costs, and laboratory testing.

Hospital-Treated Sepsis: Treatment

Gram-positive bacteria are the likely causative agents of most sepsis infections. Physicians treat the vast majority of these infections with vancomycin, piperacillin-tazobactam, levofloxacin, and ceftriaxone. After confirmatory diagnosis, over half of sepsis patients undergo a change in antibiotic therapy.

Hospital-Treated Sepsis: Treatment is part two of a two-part series on hospital-treated sepsis. This report provides quantitative, objective data focused on the treatment of sepsis requiring hospitalization. The data provides real-world patient encounters and reflects real physician decisions and encounter characteristics (e.g. patient response to therapy and outcomes) in key areas, such as antimicrobial stewardship.

Table of Contents 

  1. Patient Flow
  2. Executive Summary
  3. Incidence and Impact of Disease
    • Incidence
    • Length of Stay
    • Total Cost
  4. Patient Demographics
    • Age
    • Insurance type
    • Gender
    • Region
    • Mortality
    • Comorbid Conditions
  5. Patient Flow through the Hospital
    • Admission Site
    • Lab Testing
    • Lab TAT
    • Results
    • Etiology
    • Empiric Therapy
    • Change in treatment
  6. Drug Share for Key Therapeutics
    • Most Common
    • LOS
    • APACHE Score
    • Treatment Duration
    • Product Dashboards
      • Market Share
      • Demographics
      • Hospitalization
  7. Outcomes of Treatment
    • Antibiotic Usage
    • Mortality
    • Cost per Patient
  8. Database Overview
  9. Methodology

Instructions for Purchase:

1. Click the checkout button or go to your cart in the menu to check out

2.  Fill out in the information on the checkout page and click “Purchase”

3.  You will be redirected to a PayPal (you can check out with PayPal or any credit card by clicking “Pay with debit or credit card”)

4. Complete your purchase and click “Return to Merchant”

5. Your report will be available for download on the purchase confirmation screen and you will be e-mailed a copy of your report

Purchase